Sue Bell became one of the first Alzheimer's patients in the U.S. to receive the drug now marketed as Leqembi. Her husband ...

When people have Alzheimer’s disease, their brains slowly accumulate abnormal clumps of two proteins: amyloid and tau. At ...

Scientists have identified a biomarker for Alzheimer's that may help doctors spot the early signs of protein buildup in the ...

Su Jin Yim and colleagues argue that with the proposed definition of Alzheimer’s disease (AD) expanding in the most recent ...

Researchers from the Institut de Neurociències of the Universitat Autònoma de Barcelona (INc-UAB) have found that tau protein and beta-amyloid – two pathological hallmarks of Alzheimer’s disease – ...

If you buy through a BGR link, we may earn an affiliate commission, helping support our expert product labs. Now that iOS 18.3 has been available for almost two weeks now, we’re all wondering ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window A survey of ...

Amyloid beta forms plaques between neurons in the brain that disrupt communication between nerve cells—and has been linked to the development of Alzheimer's disease. An artist's impression of ...

2011). AD is pathologically characterized by amyloid plaque deposition, intracellular neurofibrillary tangles, and cognitive function impairment (Tanzi and Bertram, 2005). Clinical features of AD ...

AD neuropathology is due to the progressive deposition of extracellular amyloid-beta (Aβ) peptide and intracellular hyperphosphorylated tau protein. The accumulated Aβ forms amyloid plaques, while the ...

Five beta testers bring their iPhones and Galaxy devices to mobile dead zones in Alabama, Colorado, and other remote locales to try out texting on SpaceX's cellular Starlink service.